Cargando…

Upregulation of the Chemokine Receptor CCR2B in Epstein‒Barr Virus-Positive Burkitt Lymphoma Cell Lines with the Latency III Program

CCR2 is the cognate receptor to the chemokine CCL2. CCR2–CCL2 signaling mediates cancer progression and metastasis dissemination. However, the role of CCR2–CCL2 signaling in pathogenesis of B-cell malignancies is not clear. Previously, we showed that CCR2B was upregulated in ex vivo peripheral blood...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kozireva, Svetlana, Rudevica, Zhanna, Baryshev, Mikhail, Leonciks, Ainars, Kashuba, Elena, Kholodnyuk, Irina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977232/ https://www.ncbi.nlm.nih.gov/pubmed/29751565 http://dx.doi.org/10.3390/v10050239

Ejemplares similares

Expression of the Chemokine Receptor CCR1 in Burkitt Lymphoma Cell Lines Is Linked to the CD10-Negative Cell Phenotype and Co-Expression of the EBV Latent Genes EBNA2, LMP1, and LMP2
por: Zvejniece, Laura, et al.
Publicado: (2022)

Recombinant soluble CCR5 AND CXCR4 chemokine receptors as anti-HIV drug targets
por: Kurbatska, Victoria, et al.
Publicado: (2010)

Chemokine Receptors CCR1 and CCR2 on Peripheral Blood Mononuclear Cells of Newly Diagnosed Patients with the CD38-Positive Chronic Lymphocytic Leukemia
por: Kholodnyuk, Irina, et al.
Publicado: (2020)

Epstein-Barr virus and Burkitt lymphoma
por: Rowe, Martin, et al.
Publicado: (2014)

Epstein-Barr virus, malaria and endemic Burkitt lymphoma
por: Velavan, Thirumalaisamy P.
Publicado: (2018)

Burkitt Lymphomas Evolve to Escape Dependencies on Epstein-Barr Virus
por: Hutcheson, Rebecca L., et al.
Publicado: (2021)

Identification of Host Biomarkers of Epstein-Barr Virus Latency IIb and Latency III
por: Messinger, Joshua E., et al.
Publicado: (2019)

Burkitt's lymphoma: The Rosetta Stone deciphering Epstein-Barr virus biology
por: Rowe, Martin, et al.
Publicado: (2009)

Identification of Epstein-Barr Virus Replication Proteins in Burkitt’s Lymphoma Cells
por: Traylen, Chris, et al.
Publicado: (2015)

Simplified detection of Epstein-Barr virus for diagnosis of endemic Burkitt lymphoma
por: Gardner, Andrea, et al.
Publicado: (2022)

Sorting out the Superbugs: Potential of Sortase A Inhibitors among Other Antimicrobial Strategies to Tackle the Problem of Antibiotic Resistance
por: Zrelovs, Nikita, et al.
Publicado: (2021)

B cell activation and the establishment of Epstein-Barr virus latency
Publicado: (1988)

Host genetics of Epstein–Barr virus infection, latency and disease
por: Houldcroft, Charlotte J, et al.
Publicado: (2015)

Infection of Epstein–Barr Virus in Type III Latency Modulates Biogenesis of Exosomes and the Expression Profile of Exosomal miRNAs in the Burkitt Lymphoma Mutu Cell Lines
por: Nanbo, Asuka, et al.
Publicado: (2018)

Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus
por: Navari, Mohsen, et al.
Publicado: (2014)

Characterization of Epstein Barr Virus Latency Pattern in Argentine Breast Carcinoma
por: Lorenzetti, Mario A., et al.
Publicado: (2010)

Molecular Basis of Epstein–Barr Virus Latency Establishment and Lytic Reactivation
por: Murata, Takayuki, et al.
Publicado: (2021)

Parthenolide induces apoptosis and lytic cytotoxicity in Epstein-Barr virus-positive Burkitt lymphoma
por: LI, YUAN, et al.
Publicado: (2012)

Epstein–Barr virus positivity as a defining pathogenetic feature of Burkitt lymphoma subtypes
por: Leoncini, Lorenzo
Publicado: (2021)

Development of rapid antigen test prototype for detection of SARS-CoV-2 in saliva samples
por: Kivrane, Agnija, et al.
Publicado: (2022)

Epstein–Barr virus latency programs dynamically sensitize B cells to ferroptosis
por: Burton, Eric M., et al.
Publicado: (2022)

Microgeographic variations in Burkitt's lymphoma incidence correlate with differences in malnutrition, malaria and Epstein–Barr virus
por: Sumba, P O, et al.
Publicado: (2010)

How does Epstein–Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma?
por: Allday, Martin J.
Publicado: (2009)

The presence of Epstein-Barr virus significantly impacts the transcriptional profile in immunodeficiency-associated Burkitt lymphoma
por: Navari, Mohsen, et al.
Publicado: (2015)

Human and Epstein-Barr Virus miRNA Profiling as Predictive Biomarkers for Endemic Burkitt Lymphoma
por: Oduor, Cliff I., et al.
Publicado: (2017)

Epstein–Barr virus and malaria upregulate AID and APOBEC3 enzymes, but only AID seems to play a major mutagenic role in Burkitt lymphoma
por: Summerauer, Andrea M., et al.
Publicado: (2022)

Worldwide Prevalence of Epstein–Barr Virus in Patients with Burkitt Lymphoma: A Systematic Review and Meta-Analysis
por: Al-Khreisat, Mutaz Jamal, et al.
Publicado: (2023)

Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells
Publicado: (1993)

Gammaherpesvirus Latency Accentuates EAE Pathogenesis: Relevance to Epstein-Barr Virus and Multiple Sclerosis
por: Casiraghi, Costanza, et al.
Publicado: (2012)

Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency
por: Dheekollu, Jayaraju, et al.
Publicado: (2017)

Using glycyrrhizic acid to target sumoylation processes during Epstein-Barr virus latency
por: Bentz, Gretchen L., et al.
Publicado: (2019)

Burkitt's lymphoma: differential killing of Epstein-Barr virus (EBV) (+) and EBV(-) Burkitt lymphoma cells in vitro and dose-dependent lytic induction by bortezomib in vivo
por: Dufresne, AL, et al.
Publicado: (2009)

Systematic Assessment of Chemokine Signaling at Chemokine Receptors CCR4, CCR7 and CCR10
por: Lim, Herman D., et al.
Publicado: (2021)

Relationship of Epstein-Barr Virus and Interleukin 10 Promoter Polymorphisms with the Risk and Clinical Outcome of Childhood Burkitt Lymphoma
por: Minnicelli, Carolina, et al.
Publicado: (2012)

Primary Burkitt’s lymphoma of the thyroid without Epstein-Barr virus infection: A case report and literature review
por: ZHANG, LIYING, et al.
Publicado: (2014)

Coordinated repression of BIM and PUMA by Epstein–Barr virus latent genes maintains the survival of Burkitt lymphoma cells
por: Fitzsimmons, Leah, et al.
Publicado: (2018)

Epstein-Barr virus latency switch in human B-cells: a physico-chemical model
por: Werner, Maria, et al.
Publicado: (2007)

Correction: Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency
por: Dheekollu, Jayaraju, et al.
Publicado: (2019)

ΔNp63α promotes Epstein-Barr virus latency in undifferentiated epithelial cells
por: Van Sciver, Nicholas, et al.
Publicado: (2021)

RELATION BETWEEN EPSTEIN-BARR VIRAL AND CELL MEMBRANE IMMUNOFLUORESCENCE IN BURKITT TUMOR CELLS : II. COMPARISON OF CELLS AND SERA FROM PATIENTS WITH BURKITT'S LYMPHOMA AND INFECTIOUS MONONUCLEOSIS
por: Klein, G., et al.
Publicado: (1968)

Cannot write session to /tmp/vufind_sessions/sess_qpa1sbo1h4jo6f066rad1dkf35